Stock VER VERNALIS
Add to a list
To use this feature you must be a member
Log inSign up

Vernalis Share Price

Equities

VER

Biotechnology & Medical Research

Delayed London S.E.
Other stock markets
 		5-day change 1st Jan Change
- GBX -.--% Intraday chart for Vernalis +0.65% -29.32%
2017 Vernalis : hit by fresh U.S. setback for cough and cold drug RE

Chart Vernalis

Dynamic Chart

Latest news about Vernalis

Vernalis : hit by fresh U.S. setback for cough and cold drug RE
More news

Press releases Vernalis

Vernalis : AGM Statement PU
Vernalis PLC: AGM Statement MW
Vernalis : enters into research collaboration with Daiichi Sankyo PU
Vernalis : + Daiichi Sankyo Enter Collaboration MW
Vernalis : and Servier Achieve Research Milestone in Third Oncology Collaboration PU
More press releases

Managers and Directors - Vernalis

Managers TitleAgeSince
Timothy Cowper DFI
 Director of Finance/CFO - -
Sandford Sommer PSD
 President - 30/04/16
Mike Wood CTO
 Chief Tech/Sci/R&D Officer - 31/01/04
Members of the board TitleAgeSince
Matthew Foehr BRD
 Director/Board Member 51 11/10/18
Charles Berkman BRD
 Director/Board Member 55 11/10/18
Matthew Korenberg BRD
 Director/Board Member 49 11/10/18
More insiders

Company Profile

More about the company

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.51% 42.75B
LONZA GROUP AG Stock Lonza Group AG
+49.22% 41.61B
MODERNA, INC. Stock Moderna, Inc.
+8.57% 41.34B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.59B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.92% 25.49B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-25.13% 18.12B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.17% 12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.12% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.35% 11B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. VER Stock